Gold Stock News; Castle Silver Mines Inc. files final prospectus for initial public offering and "spin-out" to shareholders of Gold Bullion Development Corp.

VANCOUVER - November 16, 2011 (Investorideas.com Mining stocks Newswire) - Gold Bullion Development Corp. (TSXV: GBB, OTC PINK: GBBFF) and Castle Silver Mines Inc., a wholly-owned subsidiary of Gold Bullion, announce that Castle Silver Mines has filed a final prospectus with the securities commissions of each of the provinces of Canada in connection with an initial public offering by Castle Silver Mines, and a secondary offering to the shareholders of Gold Bullion of shares of Castle Silver Mines by way of dividend in kind.

Initial Public Offering
Castle Silver Mines is effecting an initial public offering of 4,750,000 "flow-through" units at a price of $0.40 per unit, and a minimum of 3 million and a maximum of 5 million common share units at a price of $0.30 per unit, for maximum gross proceeds to Castle Silver Mines of $3.4 million. Each "flow-through" unit will consist of one common share of Castle Silver Mines and one-half of a common share purchase warrant. Each common share unit will consist of one common share of Castle Silver Mines and one common share purchase warrant. Each full warrant will entitle its holder to acquire one additional common share of Castle Silver Mines at a price of $0.50 for a period of 18 months.
The proceeds from the initial public offering will be used by Castle Silver Mines for exploration work on its Castle Silver Mine property, future property acquisitions and for working capital and general corporate purposes. A description of the recommended exploration program for the Castle Silver Mine property is summarized in the final prospectus, which is available under Castle Silver Mines' company profile on SEDAR at www.sedar.com.
The TSX Venture Exchange has conditionally approved the listing of the common shares of Castle Silver Mines, subject to, among other standard listing conditions, completion of the initial public offering for minimum gross proceeds of $2.8 million with satisfactory public distribution.
Industrial Alliance Securities Inc. is acting as agent for the initial public offering on a "best-efforts" basis. Castle Silver Mines has granted Industrial Alliance Securities an option to offer up to 750,000 additional common share units and up to 712,500 additional "flow-through" units, representing 15% of the number of units offered, to cover over-allotments, if any. The over-allotment option may be exercised at the offering prices for a period of 30 days from the date of closing of the offering. If Industrial Alliance Securities exercises the over-allotment option in full after a maximum offering, the total gross proceeds of the offering will be $3,910,000.
Closing of the initial public offering is expected to take place no later than December 15, 2011.
"Spin-Out" to Shareholders of Gold Bullion
Concurrently with the initial public offering, Gold Bullion Development Corp., the sole shareholder of Castle Silver Mines, will distribute an aggregate of approximately 1,950,000 common shares of Castle Silver Mines to the shareholders of Gold Bullion, by way of dividend in kind. Gold Bullion shareholders will receive one common share of Castle Silver Mines for approximately every 85 issued and outstanding Gold Bullion shares on the distribution record date. The record date for the distribution of the Castle Silver Mines shares will be set by the Board of Directors of Gold Bullion in accordance with the policies of the TSX Venture Exchange. Gold Bullion will issue a press release shortly, announcing the record date and the distribution ratio. Gold Bullion will retain approximately 7.8 million shares of Castle Silver Mines.
In the event of an initial public offering by Castle Silver Mines in a maximum amount of $3.4 million, investors in the initial public offering will hold 50% of the outstanding shares of Castle Silver Mines, Gold Bullion will hold 40% of the outstanding shares, and the shareholders of Gold Bullion will hold in the aggregate 10% of the outstanding shares.
Castle Silver Mines Inc.
Castle Silver Mines Inc. was incorporated in March 2011 as a wholly-owned subsidiary of Gold Bullion, for the purpose of taking over the silver assets and exploration activities currently carried on by Gold Bullion, so that Gold Bullion can devote itself solely to exploration for gold. Prior to the distribution record date, Castle Silver Mines Inc. will acquire the Castle Silver Mine property in Gowganda, Ontario from Gold Bullion, which comprises Gold Bullion's sole silver exploration property. After such transfer, Gold Bullion does not intend to be directly involved in silver exploration. Castle Silver Mines may acquire additional interests in silver exploration properties in the future.
Castle Gold Mines' common shares have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent U.S registration or an applicable exemption from U.S. registration requirements.
About Gold Bullion Development Corp.
Gold Bullion Development Corp. is a TSX Venture-listed junior natural resource company focusing on the exploration and development of its Granada Property near Rouyn-Noranda, Qu�bec, and its Castle Silver Mine property in Gowganda, Ontario.
For more information on Gold Bullion Development Corp. (TSXV:GBB.V) (Other OTC:GBBFF.PK), visit our web site: http://www.GoldBullionDevelopmentCorp.com
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
"Frank J. Basa"
Frank J. Basa, P.Eng. President and Chief Executive Officer
Roger Thomas
Director
Tel.: (613) 292-2438
Progressive Investor Relations (Canada): Tel. (604) 689-2881 or e-mail info@progressive-ir.com
Torrey Hills Capital (United States) Tel. (858) 456-7300

Visit the GBB showcase profile at Investorideas.com
Request News and Info on GBB
Disclosure, Disclaimer/ GBB is a paid advertising client on Investorideas.com and our mining portals.

Pharma and Biotech stocks News; BioSante Pharmaceuticals (NASDAQ: BPAX) Announces Positive LibiGel® Pharmacokinetic Study Results


LINCOLNSHIRE, Ill. - November 16, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), today announced additional results from its principal LibiGel (testosterone gel) pharmacokinetic (pK) study. Top line data from this study were announced on September 12, 2011. The pK study results indicate that LibiGel increases levels of free testosterone (the active testosterone component) in the serum of postmenopausal women to within the normal ranges for younger, premenopausal women. LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in postmenopausal women, for which there is no FDA-approved product.

The pK study was conducted in 24 surgically postmenopausal subjects in three contiguous 21 day periods for a total of 63 days, in the absence of estrogen therapy (study period 1), with a concomitant transdermal estradiol patch (study period 2) and finally with concomitant oral estrogen (study period 3). LibiGel was dosed at 0.22 grams daily, the same dose as included in the two LibiGel pivotal safety and efficacy trials and safety study. The mean free testosterone level at baseline was 1.4 pg/ml. During the study, subjects in the pK study demonstrated a mean free testosterone of approximately 3.5 pg/ml on day 14, and 4.1 pg/ml on day 21 (at the end of study period 1) and approximately 4.5 pg/ml on study day 42 (at the end of 21 days of transdermal estradiol co-therapy in period 2). During study period 3, the mean free testosterone level was approximately 3.7 pg/ml. Free testosterone returned to baseline levels within 24 hours after the last dose of LibiGel, indicating effective elimination after dosing is discontinued.
The levels of free testosterone in the LibiGel pK study were similar to those seen in the BioSante LibiGel Phase II efficacy trial which ranged from 2.8 pg/ml to 3.6 pg/ml. These levels also were similar to those reported in the two pivotal testosterone patch (Intrinsa) studies which showed efficacy in treating HSDD in estrogen-treated surgically menopausal women, which were 4.0 pg/ml at 12 weeks and 3.1 pg/ml at week 24 and 4.0 pg/ml at week 24, respectively. In a recent publication, it was shown that serum testosterone concentrations in normally cycling 30-year-old pre-menopausal women range from 1.2 pg/ml to 6.4 pg/ml. However, generally, blood levels are not compared between studies because different studies performed at different times with different assays can produce varying testosterone blood levels.
In the LibiGel Phase III clinical studies, baseline testosterone levels, although collected, are not an inclusion or exclusion criterion, per FDA suggestion, since therapy for HSDD is meant for symptomatic treatment of HSDD and not testosterone levels. BioSante plans to present the full pK study results at an upcoming medical meeting. The LibiGel pK study was conducted as part of the FDA-requested studies to be submitted in the LibiGel new drug application (NDA) which is anticipated in the fourth quarter of 2012.
About LibiGel®
LibiGel is a testosterone gel in Phase III clinical development for the treatment of women who suffer from female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD). The completed Phase III efficacy trials are double-blind, placebo-controlled trials that enrolled over 500 surgically menopausal women each for six-months of therapy, approximately half of whom were taking concomitant estrogen therapy and half of whom took no concomitant estrogen therapy. The completed efficacy trials were conducted according to an FDA-agreed special protocol assessment (SPA) agreement. LibiGel is absorbed quickly through the skin after applying a once-daily pea-sized topical application on the upper arm that delivers testosterone to the bloodstream evenly over time.
In addition, BioSante is conducting the Phase III LibiGel safety study, a randomized, double-blind, placebo-controlled, multi-center, cardiovascular (CV) events and breast cancer study that has completed enrollment of 3,656 women and has accrued over 5,100 women-years of exposure, to date. The study will continue for a total of five years; however, BioSante will use the safety study data as part of an NDA submission after the last subject enrolled has completed 12 months of exposure to LibiGel or placebo.
The LibiGel safety study is tracking a predefined list of CV events, in agreement with the FDA, including CV death, myocardial infarction and stroke in women 50 years of age or older and suffering from at least two CV risk factors including hypertension and diabetes. The objective of the safety study is to demonstrate the relative safety of testosterone compared to placebo in the number of CV events. The incidence of breast cancer also is being tracked over the course of the study. The study represents the largest data base of the safety of testosterone in women.
Upon completion of the statistical analyses of efficacy trials and the safety study, BioSante intends to submit an NDA to the FDA, requesting approval of LibiGel for the treatment of HSDD in menopausal women. The NDA submission is targeted for the fourth quarter of 2012.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD), which is in Phase III clinical development according to a U.S. Food and Drug Administration (FDA) Special Protocol Assessment (SPA). BioSante's first FDA-approved product is Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, marketed in the U.S. by Azur Pharma, BioSante's licensee. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other BioSante products are Bio-T-Gel™, a testosterone gel for male hypogonadism, for which an NDA is pending, licensed to Teva Pharmaceuticals, and an oral contraceptive in Phase II clinical development. Additional information is available online at: www.biosantepharma.com.
Forward-Looking Statements
To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to future operations and products, the timing of anticipated regulatory submissions and other statements identified by words such as �will,� �continue,� �could,� �believe,� �intends,� �continue,� �expects,� �anticipates,� �estimates,� �may,� other words of similar meaning, derivations of such words or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly report on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact:
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
Harris D. McKinney, Inc.
Alan Zachary
312-506-5220
azachary@harrisdmckinney.com
BioSante Pharmaceuticals, Inc: (NASDAQ: BPAX) is a featured showcase biotech/pharma stock on Investorideas.com
Request news, updates and trading alerts on BPAX and other showcase stocks http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including biotech and pharma stocks.
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (two thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp  
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp  
Source: Investorideas.com, BioSante, Investorideas.com
800 665 0411 cvanzant@investorideas.com

Medical Technology Stock Alert: U.S FDA Clears PositiveID's (OTCBB:PSID) iglucose System for Diabetes Management

DELRAY BEACH, Fla. - November 16, 2011 (Investorideas.com Newswire) - PositiveID Corporation (OTCBB:PSID), a developer of medical technologies for diabetes management and clinical diagnostics, announced today it has received clearance from the U.S. Food and Drug Administration ("FDA") for its iglucose(TM) mobile health system for diabetes management. iglucose uses mobile technology to revolutionize the way individuals with diabetes manage their condition. By seamlessly communicating glucose readings from data-capable glucometers to the iglucose diabetes management portal, this important data can be shared with family members, caregivers and healthcare professionals. This makes it possible to improve care in a cost-effective manner and help loved ones manage their diabetes.

William J. Caragol, Chief Executive Officer of PositiveID stated, "iglucose is a safe, flexible, convenient, cost-effective and straightforward solution that we believe will revolutionize the way people with diabetes manage their condition. iglucose represents an opportunity to help decrease costs to our healthcare system by helping to improve disease management and patient compliance. This FDA clearance is an important validation of our product offering for PositiveID and we will work diligently to make iglucose available to everyone affected by diabetes in the near future."
PositiveID believes that marketplace adoption for iglucose will be led by healthcare insurers and home-healthcare providers. The business model in this market will begin with initial roll-outs, followed by an evaluation period, and leading to broad scale adoption within the patient base. Over the coming months, PositiveID expects to launch initial roll-outs with several partners that it believes can lead to large orders of iglucose. PositiveID already has the wireless infrastructure in place through partnerships with AT&T in the U.S. and Rogers Communications in Canada , and will look to add additional wireless partners.
For years the American Diabetes Association and U.S. Centers for Disease Control and Prevention ("CDC") have recommended that individuals with diabetes self-monitor and take a record of their glucose readings to their healthcare professionals. An American Association of Diabetes Educators ("AADE") positioning statement revealed that self-monitoring is the best way for people with diabetes, as well as healthcare professionals, to assess the ongoing efficacy of all aspects of the diabetes management regimen, including medication and patient behavior. The problem is that most people do not keep consistent and accurate logbooks.
iglucose eliminates the burden of keeping manual logbooks and empowers individuals with diabetes to be more engaged in the self-management of their condition. iglucose uses mobile technology to seamlessly communicate blood glucose readings from an individual's data-capable glucometer to the iglucose diabetes management portal, where, with the user's consent, glucose readings can be shared automatically with family members, caregivers and healthcare professionals via text message, email or fax. iglucose does not require the use of a cell phone or a wireless plan.
The iglucose system collects and transmits stored data from a variety of FDA cleared blood glucose meters such as the LifeScan(R) OneTouch(R), marketed by Johnson & Johnson, and Nipro Diagnostic(TM) True(TM) monitoring systems to a secure database via wireless cellular technology. A wireless data plan is not required. The Company is continually adding to this list of supported glucose meters.
PositiveID surveyed healthcare professionals at the AADE annual conference regarding the Company's iglucose mobile health communication system to facilitate diabetes management and survey results showed 83 percent of diabetes educators believe using iglucose would improve patient outcomes; 82 percent of diabetes educators believe using iglucose would improve patient consults; and 76 percent of diabetes educators would recommend iglucose to their patients.
More than 25 million children and adults in the U.S. have diabetes, or over 8 percent of the population, according to the 2011 National Diabetes Fact Sheet. The CDC predicts that nearly 30 percent of children born after the year 2000 will develop diabetes. Worldwide, the number of adults with diabetes has doubled over the last three decades to nearly 350 million and increased nearly three-fold in the U.S. , according to a study published in the British journal Lancet. The lifetime risk of developing diabetes for those born in the year 2000 is 35 percent. The total cost of diagnosed diabetes in the U.S. is estimated at $200 billion.
For more information on iglucose, please visit www.iglucose.com.
About PositiveID Corporation
PositiveID Corporation, based in Delray Beach , Florida , is a technology development company with two divisions: HealthID and MicroFluidic Systems. HealthID develops unique medical devices, focused primarily on diabetes management, and MicroFluidic Systems develops molecular diagnostic systems, focused primarily on bio-threat detection products. For more information on PositiveID, please visit www.PositiveIDCorp.com.
Statements about PositiveID's future expectations, including the likelihood that iglucose makes it possible to improve care in a cost-effective manner and help loved ones manage their diabetes; the likelihood that iglucose is a safe, flexible, convenient, cost-effective and straightforward solution for people with diabetes to revolutionize the way they manage their condition; the likelihood that iglucose represents an opportunity to help decrease costs to our healthcare system by helping to improve disease management and patient compliance; the likelihood that this FDA clearance is an important validation of the Company's product offering and the Company will work diligently to successfully make iglucose available to everyone affected by diabetes in the near future; the likelihood that the marketplace adoption for iglucose will be led by healthcare insurers and home-healthcare providers; the likelihood that the business model in this market will begin with initial roll-outs, followed by an evaluation period, and leading to broad scale adoption within the patient base; the likelihood that over the coming months, the Company will launch initial roll-outs with several partners that can lead to large orders of iglucose; the likelihood that PositiveID has the wireless infrastructure in place through partnerships with AT&T in the U.S. and Rogers Communications in Canada and will look to add additional wireless partners; the likelihood that iglucose eliminates the burden of keeping manual logbooks and empowers individuals with diabetes to be more engaged in the self-management of their condition; the likelihood that the Company is continually adding to this list of supported glucose meters; the likelihood that diabetes educators believe using iglucose would improve patient outcomes; the likelihood that diabetes educators believe using iglucose would improve patient consults; the likelihood that diabetes educators would recommend iglucose to their patients; the likelihood that nearly 30 percent of children born after the year 2000 will develop diabetes.; the likelihood that the lifetime risk of developing diabetes for those born in the year 2000 is 35 percent; the likelihood that the total cost of diagnosed diabetes in the U.S. is $200 billion; and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include PositiveID's ability to successfully commercialize iglucose and receive insurance reimbursement; as well as certain other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on March 25, 2011, and 10-Qs filed on May 13, 2011, August 15, 2011, and November 14, 2011, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
Contact:
Allison Tomek
PositiveID Corporation
561-805-8000
atomek@positiveidcorp.com

Published at Investorideas.com Newswire
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. Investorideas.com was compensated fifteen hundred to publish and distribute PositiveID Corporation press release by third party IR www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Biotech News Alert; Investor Update for BioSante Pharmaceuticals (NasdaqGM: BPAX); Jefferies Initiating at Buy: Positive Ahead of Phase III LibiGel Data


Point Roberts, WA - November 15, 2011 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues an investor update for BioSante Pharmaceuticals, Inc. (NasdaqGM: BPAX). Jefferies & Company, Inc. has initiated a buy rating on the stock with a price target of $5.00, driven by Phase III LibiGel testosterone gel.

Jefferies thinks investors should own BioSante Pharmaceuticals, Inc. (NasdaqGM: BPAX) in front of LibiGel P3 data in early December.
According to Jefferies & Company, Inc. "Our $5 PT is based on an SOTP valuation, driven primarily by a LibiGel DCF (out to 2026, discounted 15%). We assume a LibiGel partnership w/ traditional 15-25% royalties, but have milestones as upside to our model. Risks include: negative LibiGel P3 efficacy (Dec.) & safety (3Q12) results; LibiGel regulatory delay/rejection; and an inability to partner LibiGel."
About LibiGel ®
LibiGel is a testosterone gel in Phase III clinical development for the treatment of women who suffer from female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD). The completed Phase III efficacy trials are double-blind, placebo-controlled trials that enrolled over 500 surgically menopausal women each for six-months of therapy. The completed efficacy trials were conducted under an FDA-agreed special protocol assessment (SPA) agreement. LibiGel is absorbed quickly through the skin after applying a once-daily pea-sized topical application on the upper arm that delivers testosterone to the bloodstream evenly over time.
In a Phase II trial, LibiGel significantly increased the number of satisfying sexual events in surgically menopausal women suffering from FSD by 238 percent versus baseline (p<0.0001); this increase also was significant versus placebo (p<0.05). In this study, the effective dose of LibiGel produced testosterone blood levels within the normal range for pre-menopausal women and had a safety profile similar to that observed in the placebo group. In addition, no serious adverse events and no discontinuations due to adverse events occurred in any subject receiving LibiGel. The Phase II clinical trial was a double-blind, placebo-controlled trial, conducted in the United States, in surgically menopausal women distressed by their low sexual desire and activity.
About BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX)
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel ® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD), which is in Phase III clinical development according to a U.S. Food and Drug Administration (FDA) Special Protocol Assessment (SPA). BioSante's first FDA-approved product is Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, marketed in the U.S. by Azur Pharma, BioSante's licensee. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other BioSante products are Bio-T-Gel™, a testosterone gel for male hypogonadism, for which an NDA is pending, licensed to Teva Pharmaceuticals, and an oral contraceptive in Phase II clinical development. Additional information is available online at: www.biosantepharma.com.
For more information, please contact:
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
For Media:
Harris D. McKinney
Alan Zachary
312-506-5220
azachary@harrisdmckinney.com
Forward-Looking Statements
To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to future operations and products, the timing of anticipated regulatory submissions and other statements identified by words such as �will,� �continue,� �could,� �believe,� �intends,� �continue,� �expects,� �anticipates,� �estimates,� �may,� other words of similar meaning, derivations of such words or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly report on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sectors. Sectors we cover include; water stocks, gold and mining stocks, China stocks, oil and gas stocks, renewable energy stocks, coal stocks, tech stocks, biotech stocks, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. BioSante is a paid advertising biotech stock on Investorideas.com (six thousand five hundred for three months)
Source - Investorideas.com 800-665-0411
BioSante Pharmaceuticals, Inc: (NASDAQ: BPAX) is a featured showcase biotech/pharma stock on Investorideas.com
Request news, updates and trading alerts on BPAX and other showcase stocks http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including biotech and pharma stocks.
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (two thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Source: Investorideas.com, BioSante, Investorideas.com
800 665 0411 cvanzant@investorideas.com

Nanotech Stock News Alert: mPhase Technologies, Inc. (OTCBB: XDSL) Trades up over 13% Following Patent Valuation News

POINT ROBERTS - November 15, 2011 - Investorideas.com, a leader in sector research for independent investors issues the following nanotechnology stocks trading alert for mPhase Technologies, Inc. (OTCBB:XDSL). The stock is trading up at 0.0049, up 0.0006 (13.95%).

On Friday, the Company reported that mPhase's IP is valued at a Minimum of $40 Million.
The Company went on to report, "First Principals Inc., a world-class technology appraisal and commercialization firm located in Cleveland, Ohio, performed the valuation.
mPhase Technologies Intellectual Property is based upon significant research and development by the Company in the scientific disciplines of electrowetting, micro-fluid dynamics and materials science engineering at the nano-scale level.
mPhase has also licensed and further developed a patented and innovative platform technology that allows for the precise control of the flow of fluids by electronically manipulating the way fluids behave when in contact with a solid or porous surface.
mPhase has developed products based on the use of electrowetting including an infinite shelf life multiple cell emergency battery and an innovative single cell Smart Nano Battery which has received funding from The United States Army via a $750,000 STTR grant as well as a Cooperative Research and Development Agreement."
About mPhase Technologies, Inc. (OTCBB:XDSL)
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and micro fluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery.
In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website: http://www.mpowertech.com. More information about the company can be found at http://www.mPhaseTech.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Learn More about Investorideas.com Nanotech showcase stocks
http://www.investorideas.com/Nanotechnology/
Get the global stock directory of publicly traded nanotech stocks
http://www.investorideas.com/Nanotechnology/Stocks_List.asp
Sign up for the free investor news and hot stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Become a Member
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
mPhase Technologies, Inc. (XDSL.OB) is a paid showcase nanotech advertising company on Investorideas.com (fifteen hundred three months)
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411

Infrastructure/ Construction Stock News: Fireman's Contractors (OTCBB:FRCN) Launch Aggressive Franchise Development Program Aimed to Expand Market Share

DALLAS and FORT WORTH, Texas - November 15, 2011 - Fireman's Contractors Inc. (OTCBB: FRCN) (OTCQB:FRCN.OB) and its board of directors are proud to announce that it is launching its Franchise Development Program after finalizing its Federal Disclosure Document required by the Federal Trade Commission. The Franchise Development Program aims to expand market share through franchise expansion. Fireman's Contractors has put together a team of highly successful experienced franchise development professionals.

Fireman's Contractors has retained Mr. Robert Stidham, Mr. Michael Pollock and Mr. Joe Merrall from Franchise Dynamics to oversee the development, implementation and execution of the Program.
Robert Stidham is president of Franchise Dynamics, a full-service franchise sales outsourcing firm. Based in Chicago, Franchise Dynamics currently represents a number of emerging to large-sized franchisors in a wide variety of categories throughout the United States and worldwide. Mr. Stidham is active in the International Franchise Association (IFA), serving as a member of the International Committee (formerly Global Marketing Committee - GLOMAK) and Research Committee, having previously served as a member of the IFA Membership Committee. Michael Pollock, a Certified Franchise Executive (CFE), and Joe Merrell will be leads on the program.
Renee Gilmore, CEO of Fireman's Contractors stated, "This Franchise Development Program is significant for Fireman's Contractors as it will allow linear growth, expand our market share and our brand throughout the United States. The high level of experience in franchise development these individuals bring to our company provides us with not only a competitive advantage but confidence for the future of Fireman's Contractors."
The Franchise Development Program lays out the framework according to the history of success that help these professionals and their associates implement a successful facilitation of well over 7,000 franchise sales. Mr. Stidham and all of his Franchise Dynamic Associates have more than 300 cumulative years of franchise industry experience during the course of their careers.
In order to complete the regulatory elements required by the FTC, Fireman's Contractors has retained one of the most nationally recognized franchise and distribution attorneys, Cheryl Mullin of Mullin Law, P.C.
Cheryl Mullin is the founding shareholder of Mullin Law, P.C., a franchise-focused, full service commercial law firm.
Cheryl is listed in The Best Lawyers in America, a list of top attorneys in the United States, in the area of franchise law, as determined by an intensive peer review survey. She has been recognized since 2007 by "D" Magazine as one of the best lawyers in Dallas in the areas of franchise and distribution law, and by Franchise Times magazine since 2004 as a "Legal Eagle." She also was named to the Texas Super Lawyers(R) list in 2011 and is AV-rated by Martindale-Hubbell. http://www.mullinlawpc.com/
For More Information about FRCN Please Visit: www.FiremansContractors.com
About the Federal Trade Commission:
The Federal Trade Commission (FTC) is an independent Federal Government agency with a principle mission aimed at consumer protection. www.ftc.gov
About the Fireman's Contractors:
FIREMAN'S CONTRACTORS Inc. (OTCBB: FRCN) is a full service contractor providing professional services for commercial and government clients. Services include Road Improvements, Pavement Maintenance, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, and ADA Compliance. Fireman's Contractors has completed its FDD requirements with the Federal Trade Commission and has developed franchise territories across the U.S. The Company's goal is to develop hundreds of new franchise locations in the next 24 to 48 months. Fireman's Contractors brings a professional value system delivering outstanding results through honorable customer relationships and repeat business. Local firefighters are supported by a portion of profits which are donated to local Firefighter Associations.
Founded by a Firefighter, Fireman's Contractors - Contractors You Can Trust (R)
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. Additional information respecting the factors that could materially affect the Company and its operations are contained in its annual report on Form 10K and Form 10-Q as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statement.
Contact:
Fireman's Contractors Inc.
2406 Gravel Road
Fort Worth , TX 76118
Phone: 800-475-1479
info@FiremansContractors.com
http://www.Firemans-Contractors.com
Investor Relations Contact:John Pentony, IR Affiliates
Contact: john@iraffiliates.com
Tel: 469.252.3031
Public Relations Contact: Danielle O'Neal
Contact: PR@FiremansContractors.com
Tel: 800-475-1479
Follow FIREMANS CONTRACTORS, Inc. (OTCBB:FRCN) on Twitter.com
http://twitter.com/#!/firemansco
Follow FIREMANS CONTRACTORS, Inc. (OTCBB:FRCN) on Facebook.com
http://www.facebook.com/FiremansContractors

Fireman's Contractors Inc. (OTCBB:FRCN), (OTCQB:FRCN.OB) is a featured construction stock on Investorideas.com

Visit the company profile to learn more: http://www.investorideas.com/CO/FRCN/

Disclaimer/ Disclosure: FRCN has compensated Investorideas.com ten thousand for three months of advertising. All info published is sourced from public files or the Company. This is not a solicitation go buy or sell securities.

Social Media Stocks Alert: Global X Social Media Index ETF (SOCL) Starts Trading

POINT ROBERTS, Wash. - November 15, 2011 - www.InvestorIdeas.com, a global investor research portal, specializing in sector research including tech stocks issues an investor alert for social networking stocks for November 15 th. Investors following social media stocks can now trade the newly launched Global X Social Media Index ETF (NasdaqGM: SOCL).

Global X Funds, the New York based provider of exchange traded funds, today launched the Global X Social Media Index ETF, the first ETF globally to focus on social media companies.
The Global X Social Media Index ETF tracks the Solactive Social Media Index, which is designed to reflect the equity performance of companies involved in the social media industry. As of November 11, 2011, the Underlying Index's three largest stocks were DeNA Co., Sina Corp. and Netease.com Inc. International country exposure as of November 11, 2011 includes: China [36.28%], US [26.22%], Japan [19.95%], Russia [9.55%], Germany [2.28%], and other [5.65%].
The social media industry continues to grow rapidly, providing new ways for people to connect, share, shop, create and network. The Global X Social Media Index ETF attempts to capture this global industry in a single ETF, and includes companies from all over the world that provide social networking, file sharing, and other web-based media applications.
User growth in social media has skyrocketed; a Pew Research Center survey says that in 2011 approximately 65% of adult internet users said that they use a social networking site, which is nearly double the percentage that reported social network usage in 2008. An increase in mobile phone usage has further propelled social media, with nearly 40% of social media users accessing such content directly from their mobile phones (Nielsen, 2011). Not only are individual users tapped into this phenomenon, but approximately 84% of Fortune 100 companies utilize branded social media channels, while nearly 81% of the top Asian companies have expanded into branded social media channels, according to a 2011 study conducted by Burson-Marsteller. In the U.S. social media use by small businesses has grown to include nearly one out of every three businesses, demonstrating rapid growth with room for further expansion (Network Solutions, 2011).
"SOCL can provide an efficient way to tap into this global, dynamic sector," said Bruno del Ama, chief executive officer of Global X Funds. "As the industry continues to expand through IPOs, the index will capture these new companies shortly after their public debut, providing a relatively cost effective way to gain exposure to the social media industry."
ABOUT GLOBAL X FUNDS
Global X Funds is a New York-based provider of exchange-traded funds that facilitates access to investment opportunities across the global markets. With $1.4 billion in managed assets and over 100,000 investors from more than 100 countries as of October 28, 2011, Global X Funds currently offers exchange-traded funds that target Europe, Emerging Markets, Commodity Producers, Income Producers and Special Opportunities fund suites. For more information, please visit www.globalxfunds.com
Research Social Networking and Media stocks at Investorideas.com:
http://www.investorideas.com/TSS/Social_Networking_Stocks.asp
or
Join Investor Ideas Get 13 of the best stock directories online;
Research social media stocks, cloud stocks, oil and gas stocks, gold stocks, water stocks, renewable energy stocks and more
Join: http://www.investorideas.com/membership/
Sign up for the free investor news letter and get stock alerts http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
Source - Investorideas.com
800-665-0411

Monday's NASDAQ Winners: NLST, LONG, GRRF, PEIX

POINT ROBERTS - November 15, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Monday November 14th. Nasdaq ended lower by 21.53 (-0.80%) to 2,657.22.

Netlist, Inc. (NASDAQ:NLST) was biggest percentage gainer and ended with a gains of 0.43 (22.40%) to $2.35. The stock added another 36% in after-hours to $3.20. On Friday, the company reported a third-quarter loss of 4 cents a share, less than the 8.5 cent average of two analyst estimates in a Bloomberg survey.
eLong, Inc. (ADR) (NASDAQ:LONG) surged 1.97 (15.76%) to $14.47 after the company reported a profit of 4 cents a share on revenue of $25.8 million, compared to a year ago profit of a penny. The company projects to generate revenue within the range of RMB143 million to RMB155 million in the fourth quarter of 2011.
China GrenTech Corporation Limited (ADR) (NASDAQ:GRRF) gained 0.31 (12.11%) to $2.87 on very unusual volume of 276K shares, compared to its average volume of 33K shares. The CEO of the company offered to purchase the remaining stake in the company that he does not already own, a bid that values the wireless service provider at $73.4 million or $3.10 a share.
Pacific Ethanol Inc (NASDAQ:PEIX) also climbed 0.14 (15.95%) to $1.01 after it reported that on November 10, 2011, its director, W. Jones, bought 200,000 shares of the company for a total value of $145,000 at an average value of $0.725 per share.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com

TSX Stocks to Watch; Monday's Trading Leaders: (TSX: HAT), (TSX: EME), (TSX: BBD.B), (TSX: TXG)

November 15, 2011 - Investorideas.com, a leader in sector research for independent investors issues a trading alert for TSX trading leaders for November 14, 2011. The Standard & Poor's/TSX Composite Index ended lower by 52.66 (-0.43%) to close the day at 12,224.19.

Hathor Exploration Limited (TSX:HAT) was the most actively traded stock on TSX and closed with a gain of 0.40 (8.95% to C$4.87 after Cameco increased its offer to C$4.50 a share, or C$625 million, topping a rival C$4.15-a-share offer from London mining giant Rio Tinto PLC (RIO).
Emerge Oil & Gas Inc (TSX:EME) ended higher by 0.20 (20.20%) to end at $1.19 after the company reached an agreement to be acquired by Twin Butte for about C$170 million, consisting of about 54 million Twin Butte shares and about C$63 million in debt. Twin Butte is offering 0.585 of a share for each Emerge share.
Bombardier, Inc. (TSX: BBD.B ) gained 0.14 (3.30%) to C$4.38 on over 7.34 million shares. Today, Turkey's Atlasjet Havacilik has is looking to buy 10 Bombardier CS300 jetliners at a list price of $776 million, the planemaker said on Tuesday.
Torex Gold Resources Inc (TSX: TXG) shares added 0.09 (5.42%) to end at C$1.75 on over 2.59 million shares, compared to its average volume of 1.91 million shares. Torex Gold Resources Inc, formerly Gleichen Resources Ltd., is a development-stage company. It is a gold exploration company engaged in the acquisition, exploration and development of mineral property interests.
About InvestorIdeas.com: Big Ideas for small cap Investors
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Become a Member
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411

Infrastructure/ Construction Stock News: Fireman's Contractors (OTCBB:FRCN) to Showcase Business Services at the AATC Nov 15th

DALLAS and FORT WORTH, Texas - November 14, 2011 - Construction Stock News update: Fireman's Contractors Inc. (OTCBB: FRCN) (OTCQB:FRCN.OB) announced today that it will be showcasing its business services to help expand new business development and promote an increase in repeat business from its commercial clients. AATC (Apartment Association of Tarrant County) is the nation's 5th largest industry-related trade show. AATC's highly-popular regional expo is a concentrated look at more than 100 vendors, including the newest and best products and services on the market, each geared especially for property owners and managers.

Renee Gilmore, CEO of Firemans Contractors stated, "We're honored to be invited to showcase Fireman's Contractors Commercial Services to this group of professionals in the AATC. It is essential to develop relationships and expose our commercial business service to property management companies, commercial property owners and businesses to continue our high rate of growth."
Steve Winters, VP of Sales and a team of Fireman's Contractors sales associates will represent Fireman's Contractors at the event. Fireman's Contractors is a member of the AATC and views the event as an opportunity to earn new commercial business and cultivate relationships with current and repeat clients.
For More Information about FRCN Please Visit: www.FiremansContractors.com
About the AATC:
The Apartment Association of Tarrant County is a not-for-profit trade association headquartered in Fort Worth TX. We were founded in 1968 to represent multi housing owners and managers as well as industry-related products and service suppliers throughout a 9-county region of north-central Texas. The counties we serve are: Erath, Hood, Jack, Johnson, Palo Pinto, Parker, Somervell, Tarrant & Wise. AATC is committed to inspire our members with award-winning career development curricula, exemplary public advocacy initiatives, effective communication mediums and a diverse network of forums for business exchange; each designed to define our marketplace. http://aatcnet.org/
About the Fireman's Contractors:
FIREMAN'S CONTRACTORS Inc. (OTCBB: FRCN) is a full service contractor providing professional services for commercial and government clients. Services include Road Improvements, Pavement Maintenance, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, and ADA Compliance. Fireman's Contractors has completed its FDD requirements with the Federal Trade Commission and has developed franchise territories across the U.S. The Company's goal is to develop hundreds of new franchise locations in the next 24 to 48 months. Fireman's Contractors brings a professional value system delivering outstanding results through honorable customer relationships and repeat business. Local firefighters are supported by a portion of profits which are donated to local Firefighter Associations.
Founded by a Firefighter, Fireman's Contractors - Contractors You Can Trust (R)
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. Additional information respecting the factors that could materially affect the Company and its operations are contained in its annual report on Form 10K and Form 10-Q as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statement.
Contact:
Fireman's Contractors Inc.
2406 Gravel Road
Fort Worth , TX 76118
Phone: 800-475-1479
info@FiremansContractors.com
http://www.Firemans-Contractors.com
Investor Relations Contact:John Pentony, IR Affiliates
Contact: john@iraffiliates.com
Tel: 469.252.3031
Public Relations Contact: Danielle O'Neal
Contact: PR@FiremansContractors.com
Tel: 800-475-1479
Follow FIREMANS CONTRACTORS, Inc. (OTCBB:FRCN) on Twitter.com
http://twitter.com/#!/firemansco
Follow FIREMANS CONTRACTORS, Inc. (OTCBB:FRCN) on Facebook.com
http://www.facebook.com/FiremansContractors

Fireman's Contractors Inc. (OTCBB:FRCN), (OTCQB:FRCN.OB) is a featured construction stock on Investorideas.com

Visit the company profile to learn more: http://www.investorideas.com/CO/FRCN/

Disclaimer/ Disclosure: FRCN has compensated Investorideas.com ten thousand for three months of advertising. All info published is sourced from public files or the Company. This is not a solicitation go buy or sell securities.

Infrastructure Stocks:  Q&A Interview with Founders of Fireman's Contractors Inc. (OTCBB: FRCN) Work Ethics and Business Strategy for Growing Infrastructure Company

POINT ROBERTS - November 14, 2011 - www.InvestorIdeas.com, a leader in sector stock research including construction stocks, homebuilder and infrastructure stocks releases the following Q&A interview with Fireman's Contractors Inc. (OTCBB: FRCN) C.E.O , Ms. Renee Gilmore and C.O.O. Mr. Aaron Gilmore.
Ms. Renee Gilmore explains her role and vision as day to day operations manager for the contractor services Company and Mr. Aaron Gilmore, who is still a firefighter, sheds light on the spirit behind the Company’s work ethics and professionalism.

Interview:
Q: InvestorIdeas.com:
Renee, your background as a partner in a contractor company, blended with your sales and marketing at Mary Kay Inc & corporate job at TrailBlazer Health Enterprises, LLC gives you an interesting combination of skills for your business. How does this prepare you and shape your vision for the day to day operations of Fireman's Contractors?
A: Ms. Renee Gilmore, Chief Executive Officer
Interestingly enough - corporate taught me how to manage a team and interact with various departments, meet budget requirements, implement systems, policies & procedures on an ongoing basis. And, the fact that I worked in a government sector of the insurance industry, we were constantly scrutinized and performing regular audits - so attention to detail was very important. The sales and marketing experience I gained with Mary Kay Inc taught me how to lead by example, win & influence others & present myself and the opportunity at hand with a bow around it. My experiences have allowed me to blend logistics with creativity - I use to joke that I went from geek to chic. So, I think I'm now a balanced blend as it's always a balancing act between sales/marketing and operations, no matter what business you're in.
Q: InvestorIdeas.com:
Can you give us a quick overview of your services and what you feel your specialty niche is?
A: Ms. Renee Gilmore, Chief Executive Officer
We started as a painting company but found our niche in parking lot and pavement maintenance services. The fact that it's a recession resistant, repeat business and it's mandated to meet local & federal requirements, ie, ADA requirements is a big part of why it's now our specialty. And, it seemed to go hand in hand with our company name, Fireman's Contractors.
As part of our parking lot maintenance services, we offer striping, power washing, seal coating, crack filling, signage, wheel stops, asphalt & concrete repair, etc. Anything you see in the parking lot - we can provide & install, repair, etc. A small portion of our business continues to be commercial painting as a line of service.
Q: InvestorIdeas.com:
Renee, they say behind every good man there is a good woman. In your case, you stand behind all your employees. How do you pass on your passion and vision to employees you hire within the company?
A: Ms. Renee Gilmore, Chief Executive Officer
Another one of my favorite sayings is that the man is the head of the household but the woman is the neck, which turns the mans head. I believe the same is true in our business - Aaron is the founder, our business would not be where it is today without him. Based upon his passion for serving as a FireFighter in helping others and code of honor and ethics gained as a result, we operate our business in the same manner and live each day by example. I've just taken what he started and applied my business experience to the day to day operations. We're constantly communicating to our employees about ways to improve, accomplishments made, where we are and where we're headed. While we have a big vision, it's important to celebrate the milestones along the way and enjoy the journey. We have our Vision & Mission Statement posted everywhere so it's hard to forget! We've been fortunate to attract employees that are gifted and talented in their areas of expertise and are excited about what we're doing, where we're going and have the integrity that we do. We have established a team atmosphere and everyone knows they are a part of "The Contractors You Can Trust"!
Q: InvestorIdeas.com:
What is the growth strategy moving forward now that you have moved into your expanded location?
A: Ms. Renee Gilmore, Chief Executive Officer
We would like to continue growing our core business, ie. parking lot maintenance and commercial painting services. We experienced substantial growth from FYE 2010 - 2011, and we'd like to see that continue while maintaining the quality and customer service we promise to deliver. We've launched our franchise campaign and hope to gain 5 franchises during calendar year 2012. We also just recently became the first parking lot maintenance company that I know of to be publicly trading. With all of that said, we hope to continue building our name-brand image as we grow locally and nationally.
Q: InvestorIdeas.com:
Aaron, as a firefighter, you have a code of work ethics and honor that stands above the rest. How have you integrated that into your business model?
A: Mr. Aaron Gilmore, Chief Operations Officer
We have the same expectations of the crew for our parking lot maintenance as we do within the fire department & created a code of honor for the business that pertains to everyone. While the crew isn't out trying to save lives, they are serving in the community and trying to make a positive impact by performing quality work and delivering what we promise. We want to create the same type of brotherhood within our business and crews that we have at the fire station. The crew is uniformed and we try to keep our equipment and warehouse clean - just like at the fire station. It helps to have Gary Cochran, our VP of Operations, a retired Grapevine Fire Marshall of 30 years and previous owner of his own parking lot maintenance company on board to ensure our standards are met. He's been a great asset to the team & he's helped to create the same brotherhood type atmosphere within Fireman's Contractors that I experience at the station while on-duty.
Q: InvestorIdeas.com:
Can you share your vision of giving back profits back to Firemen's Associations?
A: Mr. Aaron Gilmore, Chief Operations Officer
I actively serve on our local and international Associations and have lead several initiatives in giving back to the community and non-profit organizations. So, it only seemed natural to do the same in our business. By having the business give back 1% of our proceeds to FireFighter Associations that give to organizations and local communities that help others is the least we could do. We have plans during this next Fiscal Year to not only give back monetarily as a company but also volunteer our time, & encouraging our employees to do the same, in an effort to not only help others but also to strengthen the brotherhood type atmosphere and team culture.
About Fireman's Contractors Inc. (OTCBB: FRCN)
Visit the company Profile on Investorideas.com
http://www.investorideas.com/CO/FRCN/
About Fireman's Contractors Inc. (OTCBB: FRCN)
Fireman's Contractors Inc. ( OTCBB: FRCN) is a full service contractor providing superior service in parking lot maintenance and construction services. Our services include Road Improvements, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, ADA Compliance and other construction services which are delivered at a competitive price. Fireman's brings professional value system delivering outstanding results through honorable customer relationships and repeat business. Local firefighters are supported by a portion of profits which are donated to local Firefighter Associations. http://www.firemans-contractors.com/
Follow FIREMANS CONTRACTORS, Inc. (OTCBB: FRCN) on Twitter.com
http://twitter.com/#!/firemansco
Follow FIREMANS CONTRACTORS, Inc. (OTCBB: FRCN) on Facebook.com
http://www.facebook.com/FiremansContractors
IR Contact info:
Tel: 1(214) 314-1588
Email: invest@fireamscontractors.com
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
Disclosure: Fireman's Contractors Inc. (OTCBB: FRCN) is a paid adverting construction stock on Investorideas.com and blogs (ten thousand for 3 months of advertising)
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411

Fireman's Contractors Inc. (OTCBB:FRCN), (OTCQB:FRCN.OB) is a featured construction stock on Investorideas.com

Visit the company profile to learn more: http://www.investorideas.com/CO/FRCN/

Disclaimer/ Disclosure: FRCN has compensated Investorideas.com ten thousand for three months of advertising. All info published is sourced from public files or the Company. This is not a solicitation go buy or sell securities.